Titre : Protéines de filaments intermédiaires

Protéines de filaments intermédiaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

RNA, Long Noncoding
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines de filaments intermédiaires : Questions médicales les plus fréquentes", "headline": "Protéines de filaments intermédiaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines de filaments intermédiaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-03", "dateModified": "2025-02-28", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines de filaments intermédiaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines du cytosquelette", "url": "https://questionsmedicales.fr/mesh/D003598", "about": { "@type": "MedicalCondition", "name": "Protéines du cytosquelette", "code": { "@type": "MedicalCode", "code": "D003598", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Desmine", "alternateName": "Desmin", "url": "https://questionsmedicales.fr/mesh/D003893", "about": { "@type": "MedicalCondition", "name": "Desmine", "code": { "@type": "MedicalCode", "code": "D003893", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.200" } } }, { "@type": "MedicalWebPage", "name": "Protéine gliofibrillaire acide", "alternateName": "Glial Fibrillary Acidic Protein", "url": "https://questionsmedicales.fr/mesh/D005904", "about": { "@type": "MedicalCondition", "name": "Protéine gliofibrillaire acide", "code": { "@type": "MedicalCode", "code": "D005904", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.400" } } }, { "@type": "MedicalWebPage", "name": "Kératine-15", "alternateName": "Keratin-15", "url": "https://questionsmedicales.fr/mesh/D053569", "about": { "@type": "MedicalCondition", "name": "Kératine-15", "code": { "@type": "MedicalCode", "code": "D053569", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.450.300.500" } } }, { "@type": "MedicalWebPage", "name": "Vimentine", "alternateName": "Vimentin", "url": "https://questionsmedicales.fr/mesh/D014746", "about": { "@type": "MedicalCondition", "name": "Vimentine", "code": { "@type": "MedicalCode", "code": "D014746", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.220.475.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines de filaments intermédiaires", "alternateName": "Intermediate Filament Proteins", "code": { "@type": "MedicalCode", "code": "D007381", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sarah Köster", "url": "https://questionsmedicales.fr/author/Sarah%20K%C3%B6ster", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Goettingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Sandrine Etienne-Manneville", "url": "https://questionsmedicales.fr/author/Sandrine%20Etienne-Manneville", "affiliation": { "@type": "Organization", "name": "Cell Polarity, Migration and Cancer Unit, Institut Pasteur, UMR3691 CNRS, Équipe Labellisée Ligue Contre le Cancer, F-75015 Paris, France. Electronic address: setienne@pasteur.fr." } }, { "@type": "Person", "name": "Charlotta Lorenz", "url": "https://questionsmedicales.fr/author/Charlotta%20Lorenz", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Anna V Schepers", "url": "https://questionsmedicales.fr/author/Anna%20V%20Schepers", "affiliation": { "@type": "Organization", "name": "Institute for X-Ray Physics, University of Göttingen, Friedrich-Hund-Platz 1, 37077 Göttingen, Germany." } }, { "@type": "Person", "name": "Rudolf E Leube", "url": "https://questionsmedicales.fr/author/Rudolf%20E%20Leube", "affiliation": { "@type": "Organization", "name": "Institute of Molecular and Cellular Anatomy, RWTH Aachen University, Aachen, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Transcriptome analysis identification of A-to-I RNA editing in granulosa cells associated with PCOS.", "datePublished": "2023-07-21", "url": "https://questionsmedicales.fr/article/37547318", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1170957" } }, { "@type": "ScholarlyArticle", "name": "Improved RNA stability estimation indicates that transcriptional interference is frequent in diverse bacteria.", "datePublished": "2023-07-15", "url": "https://questionsmedicales.fr/article/37454177", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s42003-023-05097-2" } }, { "@type": "ScholarlyArticle", "name": "The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification.", "datePublished": "2023-07-10", "url": "https://questionsmedicales.fr/article/37430472", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/mgg3.2232" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of rRNA depletion methods for capturing the RNA virome from environmental surfaces.", "datePublished": "2023-07-07", "url": "https://questionsmedicales.fr/article/37420286", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13104-023-06417-9" } }, { "@type": "ScholarlyArticle", "name": "The Incidence of Graves' Hyperthyroidism Before and After COVID-19 Messenger RNA Vaccination.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37391042", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.eprac.2023.05.005" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines du cytosquelette", "item": "https://questionsmedicales.fr/mesh/D003598" }, { "@type": "ListItem", "position": 5, "name": "Protéines de filaments intermédiaires", "item": "https://questionsmedicales.fr/mesh/D007381" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines de filaments intermédiaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines de filaments intermédiaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Protéines de filaments intermédiaires", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D007381?mesh_terms=RNA,+Long+Noncoding&page=996#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }

Sources (10000 au total)

Transcriptome analysis identification of A-to-I RNA editing in granulosa cells associated with PCOS.

Polycystic ovary syndrome (PCOS) is a complex, multifactor disorder in women of reproductive age worldwide. Although RNA editing may contribute to a variety of diseases, its role in PCOS remains uncle... A discovery RNA-Seq dataset was obtained from the NCBI Gene Expression Omnibus database of granulosa cells from women with PCOS and women without PCOS (controls). A validation RNA-Seq dataset download... A total of 17,395 high-confidence A-to-I RNA editing sites were identified in 3,644 genes in all GC samples. As for differential RNA editing, there were 545 differential RNA editing (DRE) sites in 259... Our current study highlighted the potential role of RNA editing in the pathophysiology of PCOS as an epigenetic process. These findings could provide valuable insights into the development of more tar...

The effect of a single SMARCA4 exon deletion on RNA splicing: Implications for variant classification.

Exon deletions are generally considered pathogenic, particularly when they are located out of frame. Here, we describe a pediatric, female patient presenting with hypercalcemia and a small cell carcin... The SMARCA4 deletion was identified by whole genome sequencing, and the effect on the RNA level was examined by gel- and capillary electrophoresis and nanopore sequencing.... The deletion was in silico predicted to be truncating, but RNA analysis revealed two major transcripts with deletion of exon 14 alone or exon 14 through 15, where the latter was located in-frame. Beca... We propose to include RNA analysis in classification of single-exon deletions, especially if located outside of known functional domains, as this can identify any disparate effects on the RNA and DNA ...

Evaluation of rRNA depletion methods for capturing the RNA virome from environmental surfaces.

Metatranscriptomic analysis of RNA viromes on built-environment surfaces is hampered by low RNA yields and high abundance of rRNA. Therefore, we evaluated the quality of libraries, efficiency of rRNA ... Good-quality RNA libraries were obtained from 0.1 ng of mock community and table surface RNA by changing the adapter concentration and number of PCR cycles. Differences in the target species of the rR...

The Incidence of Graves' Hyperthyroidism Before and After COVID-19 Messenger RNA Vaccination.

Case reports of postvaccine early-onset Graves' hyperthyroidism (PVGD) after the administration of COVID-19 vaccination have emerged. Our aim was to investigate whether the incidence of Graves' hypert... We compared the incidence of new-onset GD at a single academic center during 2 periods: December 2017 to October 2019 and December 2020 to October 2022, ie, before and after the implementation of COVI... During the prevaccination period, 803 patients carried diagnoses of GD, and of these, 131 were new. During the postvaccination period, 901 patients carried diagnoses of GD, and of these, 138 were new.... There was no increase in new-onset GD after COVID-19 vaccination. Median free T4 was higher in patients with PVGD, but this was not statistically significant....